You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 21, 2024

Flortaucipir f-18 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for flortaucipir f-18 and what is the scope of patent protection?

Flortaucipir f-18 is the generic ingredient in one branded drug marketed by Avid Radiopharms Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Flortaucipir f-18 has twenty-six patent family members in sixteen countries.

One supplier is listed for this compound.

Summary for flortaucipir f-18
International Patents:26
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 4
Clinical Trials: 21
Patent Applications: 18
What excipients (inactive ingredients) are in flortaucipir f-18?flortaucipir f-18 excipients list
DailyMed Link:flortaucipir f-18 at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for flortaucipir f-18
Generic Entry Date for flortaucipir f-18*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for flortaucipir f-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Neuroscience Trials AustraliaPhase 2
Tharick PascoalPhase 1
Seelos Therapeutics, Inc.Phase 2

See all flortaucipir f-18 clinical trials

US Patents and Regulatory Information for flortaucipir f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avid Radiopharms Inc TAUVID flortaucipir f-18 SOLUTION;INTRAVENOUS 212123-002 May 28, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Avid Radiopharms Inc TAUVID flortaucipir f-18 SOLUTION;INTRAVENOUS 212123-004 Jul 1, 2022 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Avid Radiopharms Inc TAUVID flortaucipir f-18 SOLUTION;INTRAVENOUS 212123-001 May 28, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Avid Radiopharms Inc TAUVID flortaucipir f-18 SOLUTION;INTRAVENOUS 212123-002 May 28, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Avid Radiopharms Inc TAUVID flortaucipir f-18 SOLUTION;INTRAVENOUS 212123-003 Jul 1, 2022 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Avid Radiopharms Inc TAUVID flortaucipir f-18 SOLUTION;INTRAVENOUS 212123-001 May 28, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for flortaucipir f-18

Country Patent Number Title Estimated Expiration
South Korea 20100135235 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION ⤷  Try a Trial
European Patent Office 2599763 Nouveaux agents d'imagerie pour la détection d'un dysfonctionnement neurologique (Novel imaging agents for detecting neurological dysfunction) ⤷  Try a Trial
Canada 2873963 AGENTS D'IMAGERIE A BASE DE CARBOLINE ET DE CARBAZOLE POUR LA DETECTION DE DYSFONCTION NEUROLOGIQUE (CARBOLINE AND CARBAZOLE BASED IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION) ⤷  Try a Trial
Hungary E058352 ⤷  Try a Trial
China 104781234 Carboline and carbazole based imaging agents for detecting neurological dysfunction ⤷  Try a Trial
China 107011342 用于检测神经功能障碍的基于咔啉和咔唑的成像剂 (CARBOLINE AND CARBAZOLE BASED IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.